{"id":20344,"date":"2021-03-12T16:02:34","date_gmt":"2021-03-12T16:02:34","guid":{"rendered":"https:\/\/dejalex.com\/it\/2021\/03\/lotta-contro-il-coronavirus-via-libera-al-quarto-vaccino-johnson-johnson\/"},"modified":"2021-03-12T16:05:12","modified_gmt":"2021-03-12T16:05:12","slug":"lotta-contro-il-coronavirus-via-libera-al-quarto-vaccino-johnson-johnson","status":"publish","type":"post","link":"https:\/\/www.dejalex.com\/it\/2021\/03\/lotta-contro-il-coronavirus-via-libera-al-quarto-vaccino-johnson-johnson\/","title":{"rendered":"LOTTA CONTRO IL CORONAVIRUS. VIA LIBERA AL QUARTO VACCINO JOHNSON &#038; JOHNSON"},"content":{"rendered":"<p>Dopo quelli sviluppati da BionNTech-Pfizer (\u201cPfizer\u201d), Moderna e AstraZeneca, in data 11 marzo 2021 la Commissione Europea ha rilasciato un\u2019autorizzazione all\u2019immissione in commercio condizionata (Conditional Marketing Authorization, CMA) per il vaccino contro il coronavirus messo a punto dalla controllata europea del gruppo Johnson &amp; Johnson, Janssen Pharmaceutica NV (\u201cJanssen\u201d), la cui domanda era stata presentata il 16 febbraio 2021&#8230;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-2114 aligncenter\" src=\"https:\/\/dejalex.com\/it\/wp-content\/uploads\/2021\/03\/Articolo-Lotta-contro-il-coronavirus.-Via-libera-al-quarto-vaccino-Johnson-Johnson.jpg\" alt=\"\" width=\"557\" height=\"789\"><\/p>\n<p style=\"text-align: center;\"><a href=\"https:\/\/dejalex.com\/it\/wp-content\/uploads\/2021\/03\/Articolo-Lotta-contro-il-coronavirus.-Via-libera-al-quarto-vaccino-Johnson-Johnson.pdf\" target=\"_blank\" rel=\"noopener\"><i  class=\"x-icon x-icon-download\" data-x-icon-s=\"&#xf019;\" aria-hidden=\"true\"><\/i> Scarica l&#8217;articolo<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[x_icon type=\"tag\"] Coronavirus, UE e Politiche Generali, Farmaceutico e Life Sciences, Prospettive<\/p>\n","protected":false},"author":3,"featured_media":17673,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[439,370,402,422,307,444],"tags":[],"class_list":["post-20344","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-coronavirus-it","category-farmaceutico-e-life-sciences","category-prospettive","category-pubblicazioni","category-roberto-jacchia-it","category-ue-e-politiche-generali"],"_links":{"self":[{"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/posts\/20344","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/comments?post=20344"}],"version-history":[{"count":1,"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/posts\/20344\/revisions"}],"predecessor-version":[{"id":20346,"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/posts\/20344\/revisions\/20346"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/media\/17673"}],"wp:attachment":[{"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/media?parent=20344"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/categories?post=20344"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/tags?post=20344"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}